Cartesian Therapeutics (RNAC) Return on Invested Capital (QoQ) (2022)

Cartesian Therapeutics (RNAC) Return on Invested Capital (QoQ) (2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn -
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn -
3 Akari Therapeutics 989.71 Bn 989.71 Bn -
4 BeOne Medicines 471.62 Bn 466.83 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.98 Bn 61.22 Bn 3.31 Bn
7 Belite Bio 62.68 Bn 62.68 Bn -
8 Argenx Se 55.75 Bn 50.57 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn
10 Cartesian Therapeutics 214.57 Mn 214.57 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 -1.00